Objective
THE SCOPE OF THE PROJECT ENCOMPASSES THE INTEREST OF FAMILIES AFFECTED WITH DISEASES INVOLVING SINGLE MENDELIAN DISORDERS (LIKE DUCHENNE'S MUSCULAR DYATROPHY, NEUROFIBROMATOSIS, POLYPOSIS COLI AND THE COLLAGNE-DISORDERS, E.G. MARFAN'S SYNDROME AND OSTEOGENESIS IMPERFECTA) IN ALL EUROPEAN COUNTRIES. IT WILL BECOME AN ESSENTIAL SOURCE OF INFORMATION FOR PRESENT AND FUTURE RESEARCH, TO BE CONTINUED DURING A PERIOD OF AT LEAST TWO GENERATIONS.
REASONS FOR THIS ARE :
- MANY GENETIC DISORDERS DO NOT GIVE SYMPTOMS BEFORE ADULT AGE,
- IN EVERY SINGLE FAMILY, AS MANY INFORMATIVE SUBJECTS (BOTH AFFECTED AND UNAFFECTED) MUST BE AVAILABLE FOR THE STUDY, FOR INSTANCE IN THE TESTING OF A (PRESYMPTOMATIC) DIAGNOSTIC TEST.
- NEW TECHNOLOGIES (LIKE DNA-PROBES) ARE BEING DEVELOPED AT A RAPID RATE, AND THEIR TESTABILITY GREATLY DEPENDS UPON INFORMATIVE MATERIALS FROM WELL-STUDIED FAMILIES,
- FOR THE TESTING OF ANY DNA, ENZYMATIC OR BIOCHEMICAL MARKER, CELL MATERIAL FROM MULTIPLE GENERATIONS FROM EVERY SINGLE FAMILY (INCLUDING BOTH AFFECTED PROBAND(S) AND UNAFFECTED RELATIVES) IS ESSENTIAL TO ESTABLISH ANY RELEVANT SEGREGATION PATTERN, USEFUL IN CONSTRUCTING AN INFORMATIVE AND RELIABLE DIAGNOSTIC TEST. THE HETEROGENEITY WITHIN MANY GENETIC DISORDERS MAKES IT ESSENTIAL, THAT THESE DATA ARE OBTAINED FROM EVERY SINGLE INDIVIDUAL FAMILY TO BE STUDIED PROSPECTIVELY IN THE FUTURE.
Recent years have seen rapid progress in the genetic mapping of human gene disorders. The generation of a collection of cell lines from patients and their families with genetic disorders provides the research community with an invaluable resource.
The human cell bank (HCB) was generated from blood samples received from patients with genetic disorders. The B lymphocytes were separated from the blood and immortalized with Epstein-Barr virus (EBV). A human and viral deoxyribonucleic acid (DNA) probe bank was also established and a catalogue containing information on all the cell lines and probes collected was published.
During the last 4 years, HCB received over 600 blood samples from depository centres throughout Europe and even as far afield as Brazil and Canada. Examples of some of the more common disorders so far collected include: muscular dystrophy, diabetes, cystic fibrosis, schizophrenia, tuberous sclerosis and many other less common disorders. The overall success rate for obtaining an established cell line from blood samples was 90% and these cell lines are available to the scientific community. 100 DNA probes have been collected, mainly X chromosome specific and Y chromosome specific, but also including some viruses.
A catalogue including all the above material has been published and distributed annually for the past 2 years.
IT IS THE OBJECT OF THIS PROJECT TO ESTABLISH A HUMAN GENETIC MUTANT CELL BANK DERIVED FROM FAMILIES WITH A WELL DOCUMENTED DIAGNOSTIC HISTORY OF DISEASE ASSOCIATION. THIS WILL ALSO INCLUDE NORMAL (CONTROL) MATERIAL. THUS A READILY ACCESSIBLE SOURCE OF DNA WILL BE MADE AVAILABLE VIA LONG-TERM CELL CULTURES.
A COLLECTION OF :
(I) FIBROPLASTIC CELL LINES OBTAINED BY SKIN BIOPSY.
(I) B-LYMPHOBLASTOID CELL LINES DERIVED FROM LYMPHOCYTES ISOLATED FROM BLOOD SAMPLES TAKEN FROM PATIENTS AND DESPATCHED TO THE NCACC LABORATORIES. TRANSFORMATION IN VITRO WITH EPSTEIN-BARR VIRUS RESULTS IN AN IMMORTALISED CELL LINE WITH AN INFINITE LIFE SPAN.
ONCE CELL LINES ARE ESTABLISHED A DISTRIBUTION STOCK WILL BE PREPARED IN THE NCACC LABORATORIES AND WILL BE MADE AVAILABLE TO EUROPEAN SCIENTISTS FOR R & D AND DIAGNOSTIC WORK.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine neurology muscular dystrophies
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences genetics DNA
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences clinical medicine psychiatry schizophrenia
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
SALISBURY
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.